TalpheraTLPH
Fair Value
US$3.25
Share price15 Dec
US$1.3558.5% undervalued intrinsic discount
1Y219.07%
7D1.89%
Regional Anticoagulant Adoption Will Drive Long Term Opportunity In Renal Replacement Therapy
AN
Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.
Published
15 Dec 25
Views
27
Not Invested